Amarin reported $233.2M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Amarin USD 290M 51M Dec/2025
AstraZeneca USD 213.88B 23.43B Nov/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
DBV Technologies USD 739M 491M Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Halozyme Therapeutics USD 15.62B 3.09B Nov/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 4.24B 3.18B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neurocrine Biosciences USD 16.38B 1.96B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026